🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07369908
Recruiting Not applicable

The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation

NCT07369908 · tracked via the Priya Life Science China tracker
Sponsor
University of Electronic Science and Technology of China
Phase
Not applicable
Started
2025-10-09
Last updated
2026-01-27

Condition(s) studied

Healthy Male and Female Volunteers

Investigational drug(s) / intervention(s)

taVNS on tragus of subjects with high trait anxietytaVNS on earlobe of subjects with high trait anxietytaVNS on tragus of subjects with no high trait anxietytaVNS on earlobe of subjects with no high trait anxiety

taVNS on tragus of subjects with high trait anxiety: 15 minutes taVNS on tragus

taVNS on earlobe of subjects with high trait anxiety: 15 minutes taVNS on earlobe

taVNS on tragus of subjects with no high trait anxiety: 15 minutes taVNS on tragus

taVNS on earlobe of subjects with no high trait anxiety: 15 minutes taVNS on earlobe

Study summary

The main aim of this study is to investigate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce anxiety and have an effect on emotional regulations

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy subjects without past or current psychiatric or neurological disorders. Exclusion Criteria: * History of head injury. * Medical or psychiatric illness. * Subjects take a certain drug for a long period of time. * Subjects have metal implants in their bodies.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Electronic Science and Technology of China (UESTC) Chengdu Sichuan Recruiting

More University of Electronic Science and Technology of China trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07369908 on ClinicalTrials.gov ↗ ← All trials in China